Molecular biomarker testing for non–small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group

Molecular biomarker testing is the standard of care for non–small cell lung cancer (NSCLC) patients. In 2017, the Korean Cardiopulmonary Pathology Study Group and the Korean Molecular Pathology Study Group co-published a molecular testing guideline which contained almost all known genetic changes th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Pathol Transl Med
Main Authors: Chang, Sunhee, Shim, Hyo Sup, Kim, Tae Jung, Choi, Yoon-La, Kim, Wan Seop, Shin, Dong Hoon, Kim, Lucia, Park, Heae Surng, Lee, Geon Kook, Lee, Chang Hun
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Society of Pathologists and the Korean Society for Cytopathology 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8141968/
https://ncbi.nlm.nih.gov/pubmed/33966368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/jptm.2021.03.23
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados